drugset / Trial / NCT01057693

Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy

NCT01057693

Phase 3 Completed 633 enrolled Viatris Inc.
RandomizedQuadruple-blindTreatment

Summary

Patients will be switched from their current medication for painful diabetic peripheral neuropathy to evaluate the safety and efficacy of pregabalin as compared to placebo. All patients will receive pregabalin, and half of patients will receive placebo at some point during the study.

Timeline

Start
2010-03-31
Primary completion
2012-01-30
Completion
2012-01-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 150 mg
Subject Pregabalin Small molecule 300 mg